Teva gets approval to sell generic anti-nausea drug
- Share via
Teva Pharmaceutical Industries Ltd. said it had won regulatory approval to sell a generic version of an anti-nausea drug used by chemotherapy patients.
The Food and Drug Administration approved Teva’s application to sell the drug ondansetron, which is a generic version of GlaxoSmithKline’s Zofran.
The Israeli company said it planned to sell the drug packaged in 4-milligram single-dose vials, in multiple-dose vials and in bags.
Shares of Teva were up 31 cents at $32.56 after the FDA approval announcement.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
